Background: It is unknown whether regional measures of skeletal muscle (SM) in the thigh and abdomen accurately reflect wholebody SM mass. Objective: We aimed to determine whether thigh and abdominal SM measures reflect whole-body SM mass and, if so, which region is a stronger marker. Design: Whole-body and regional measures of SM were obtained by magnetic resonance imaging in a sample of 387 white men and women. Results: The regional SM measures, whether obtained by using a single image (midthigh or L4-L5 level) or a series of 7 consecutive images covering 31 cm (thigh or abdomen), were strongly correlated with whole-body SM (P 0.001). Independent of sex, the thigh SM measures derived from a single image (men: R 2 ҃ 0.77, SEE ҃ 6.5%; women: R 2 ҃ 0.79, SEE ҃ 7.4%) or a series of 7 consecutive images (men: R 2 ҃ 0.84, SEE ҃ 5.4%; women: R 2 ҃ 0.90, SEE ҃ 5.1%) were stronger correlates of whole-body SM with smaller SEE values than were the abdominal SM measures (P 0.01). However, SM in the abdomen was also a strong marker of whole-body SM, whether determined from a single image at the L4-L5 level (men: R 2 ҃ 0.63, SEE ҃ 8.2%; women: R 2 ҃ 0.58, SEE ҃ 10.4%) or from a series of images across the abdomen (men: R 2 ҃ 0.77, SEE ҃ 6.5%; women: R 2 ҃ 0.70, SEE ҃ 8.7%). Conclusion: Although thigh measures of SM are better predictors of whole-body SM, a single image within the abdomen routinely used to estimate abdominal fat may also be a useful marker of whole-body SM.
INTRODUCTION
Accurate measurement of skeletal muscle (SM) is essential in many fields of nutrition, applied physiology, and clinical medicine (1, 2) . Computed tomography (CT) and magnetic resonance imaging (MRI) provide accurate measures of SM tissue (3) (4) (5) , and protocols that use multiple images covering the entire body are the criterion method for measurement of whole-body SM (5) . However, cost, accessibility, and ionizing radiation (in the case of CT) limit the use of whole-body imaging. Thus, it is common for investigators and clinicians to use a single image (area, in cm 2 ) for the purpose of estimating whole-body SM. Because 50% of the SM tissue is located in the lower extremity, with much of this muscle located in the thigh region (6) , most studies select the midthigh region for SM measurement (5) . Although a single image is routinely used to quantify SM, some investigators have hypothesized that the SM volume or mass obtained from a series of multiple images in the thigh would be a stronger predictor of whole-body SM (5, 7, 8) . In fact, at present it is unknown whether measures of SM in the thigh region, obtained by using a single image or multiple images, accurately reflect whole-body SM mass.
MRI and CT have also been used extensively in obesity research to examine fat distribution in the abdomen. In most studies, abdominal subcutaneous and visceral fat area are quantified at a level corresponding to the intervertebral disk between the 4th and 5th lumbar vertebrae (L4-L5) (5, 9) . Some investigators have used multiple imaging protocols to determine the volume or mass of subcutaneous and visceral fat over the entire abdominal region (5, 9 -12) . In addition to subcutaneous and visceral fat, SM can be quantified in these abdominal images. To our knowledge, no previous study has examined whether measures of SM in the abdomen relate to whole-body SM mass.
The purpose of the present study was twofold. First, we sought to determine whether regional measures of SM in the thigh and abdomen accurately reflect whole-body SM mass and, if so, which region is a stronger indicator of whole-body SM. Second, we sought to determine whether measures of SM obtained from a single MRI image are as strong a marker of whole-body SM mass as are measures of SM obtained from a series of multiple MRI images. To address these questions, we measured wholebody and regional SM with MRI in a heterogeneous sample of 387 white men and women.
SUBJECTS AND METHODS

Study population
The subjects consisted of healthy white men (n ҃ 190) and women (n ҃ 197) who participated in various body-composition studies at Queen's University (Kingston, Canada) and St Luke's-Roosevelt Hospital (New York). Although the subjects varied widely in age (18 -88 y) and body mass index (BMI, in kg/m 2 : 16 -40), most were middle-aged (65% were aged between 30 and 55 y) and overweight (27% had a BMI of 25-29.9) or obese (46% had a BMI ͧ30). Two hundred ninety-eight subjects from Queen's University and 89 subjects from Columbia University were recruited from among hospital employees, students at local universities, and the general public through posted flyers and the local media. All participants gave informed consent before participation in accordance with the ethical guidelines of the respective institutional review boards.
Measurement of skeletal muscle by magnetic resonance imaging
The MRI images were obtained with a General Electric 1.5-T scanner (Milwaukee). A T1-weighted, spin-echo sequence with a 210-ms repetition time and a 17-ms echo time was used to obtain the MRI data. The MRI protocol is described in detail elsewhere (10) . Briefly, the subjects lay in the magnet in a prone position with their arms placed straight overhead. With use of the L4 -L5 as the point of origin, transverse images (10-mm image thickness) were obtained every 40 mm from hand to foot. Three series of 7 images were obtained for the lower body, and 3 series of 7 images were obtained for the upper body. The total time required to acquire all of the MRI data for each subject was Ȃ30 min.
Segmentation and calculation of skeletal muscle area, volume, and mass
Once acquired, the MRI data were transferred to a personal computer for analysis with specially designed image analysis software (SLICE-O-MATIC; Tomovision Inc, Montreal), the procedures for which are fully described and illustrated elsewhere (3, 10, 13) . Briefly, a multiple-step procedure was used to identify tissue area (cm 2 ) for a given MRI image. In the first step, a filter distinguished between different gray-level regions on the images, and lines were drawn around the different regions by using a watershed algorithm. The observer then labeled the different tissues by assigning them different codes. Each image was reviewed by an interactive slice-editor program that allowed for verification and, where necessary, correction of the segmented results. The original gray-level image was superimposed on the binary segmented image by using a transparency mode to facilitate the corrections. The area (cm 2 ) of adipose tissue-free SM in each image was computed automatically by summing the SM pixels and multiplying by the individual pixel surface area. The volume (cm 3 ) of SM in each image was calculated by multiplying tissue area (cm 2 ) by the image thickness (10 mm). The SM volume for the space between 2 consecutive images (40 mm) was calculated by using a mathematical algorithm given elsewhere (3) . Volume units (L) were converted to mass units (kg) by multiplying the volumes by the assumed constant density (1.04 kg/L) for adipose tissue-free SM (14) .
Selection and determination of regional skeletal muscle measures
Whole-body SM was calculated by using all 41 images. The regional measures were determined by using the thigh and abdominal regions because they are commonly used in imaging studies that measure regional SM or fat. For both regions, the area (cm 2 ) values of SM obtained from a single image and the mass (kg) values of SM derived from a series of 7 consecutive images were compared with whole-body SM mass (kg). Midthigh SM area (cm 2 ) was measured at a level 20 cm below the femoral head (image 14 in Figure 1 ). This approach facilitated the use of a common landmark and represents an area in the thigh with a large amount of SM. SM mass in the thigh was calculated by using a series of 7 images beginning at the femoral head and extending to 31 cm below the femoral head (7 ҂ 10 mm thick images ѿ 6 ҂ 40 mm spaces between images ҃ 31 cm; images 12-18 in Figure 1 ). Abdominal SM area (cm 2 ) was measured at the level of the L4 -L5 intervertebral disk (Figure 2 ; image 21 in Figure  1 ). SM mass (kg) in the abdomen was calculated by using a series of 7 images extending from 5 cm below L4 -L5 to 25 cm above L4 -L5 [images 20 -26 (31 cm in total) in Figure 1 ]. This approach facilitated the use of a common landmark (L4 -L5) and corresponds with a region that has been used extensively to measure abdominal subcutaneous and visceral fat (5, 9) .
Reliability of magnetic resonance imaging measurements
We determined the reproducibility of the MRI SM measurements by comparing the intra-and interobserver estimates for the measurements (one series of 7 images taken in the legs) obtained in 3 male and 3 female subjects (3). The interobserver difference was 1.8 Ȁ 0.6% and the intraobserver difference was 0.34 Ȁ 1.1% (3). The intraobserver difference was calculated by comparing the analysis of 2 separate MRI acquisitions in a single observer, whereas the interobserver difference was determined by comparing 2 observers' analyses of the same images. We determined the reproducibility of the MRI SM measurements across the laboratories by comparing the 2 laboratories' analyses of the same images (whole body) for 5 subjects. The interlaboratory difference was 2.0 Ȁ 1.2% (6) .
Statistical analysis
Statistical procedures were performed by using SPSS version 11.0 (SPSS Inc, Chicago). Differences between men and women were tested for significance by using unpaired t tests. Pearson's correlations were performed to determine the relations between whole-body SM and regional SM measurements. The strength of the correlations was compared by using the Hotelling method (15) . The strength of the SEE values was compared by using Pitman's test (16) .
To determine whether there was a nonlinear relation between the various regional SM measures and whole-body SM mass, each of the regional measures was regressed by using a full cubic polynomial (regional SM measure, regional SM measure 2 , regional SM measure 3 ). Multiple-regression analysis and analysis of variance were used to determine sex differences in the slopes and intercepts of the regression lines.
RESULTS
The subjects' characteristics are given in Table 1 . The men and women did not differ significantly in average age or BMI (P 0.1). The general distribution of SM across the whole body for men and women is illustrated in Figure 1 . In general, men had a higher SM area (cm 2 ) per image across the body. In men, 31% of whole-body SM was located in the thigh region (images [12] [13] [14] [15] [16] [17] [18] , and 15% of whole-body SM mass was in the abdomen (images 20 -26). In women, 33% of whole-body SM mass was in the thigh region, and 15% was in the abdomen.
The variances in whole-body SM mass explained by the regional measures of SM are listed in Table 2 . Within both sexes, whether obtained by using a single image (area in cm 2 , 1-cm thick region) or a series of 7 images (mass in kg, 31-cm thick region), the thigh and abdominal SM measures were all strongly related to whole-body SM mass (P 0.001). In both men and women, the thigh SM measures were stronger correlates of whole-body SM than were the abdominal SM measures (P 0.01), and the SEE values were smaller for the thigh measures (P 0.01). Furthermore, independent of sex, the mass of SM in the thigh region (31-cm thick region) was a stronger correlate of wholebody SM mass than was the area (1-cm thick region) of SM in the single thigh image (P 0.01), despite the fact that midthigh SM area was highly correlated with thigh SM mass (R 2 ҃ 0.72 in men, P 0.001; R 2 ҃ 0.72 in women, P 0.001). Similarly, abdominal SM mass was a stronger correlate of whole-body SM than was the area of SM in the L4-L5 image (P 0.01), despite the fact that L4-L5 SM area was highly correlated with abdominal SM mass (R 2 ҃ 0.88 in men, P 0.001; R 2 ҃ 0.92 in women, P 0.001). For both the thigh and abdominal regions, the SEE values were smaller (P 0.01) for the mass measurements than for the area measurements ( Table 2) .
The relations between each of the thigh (images 12-18 in Figure 1 ) and abdominal (images 20 -26 in Figure 1 ) images with whole-body SM are provided in Table 3 . For the thigh, the highest R 2 value with the lowest SEE was obtained at midthigh (image 14) for both men and women. Independent of sex, the SM area values obtained for the 4 images beginning at a point 10 cm below the femoral head (image 16) and extending to 25 cm below the femoral head (image 13) were all strongly related to wholebody SM mass. For the abdomen, the highest R 2 value with the lowest SEE was obtained at the image located 5 cm above L4-L5 (image 22). The data in Table 3 also show that the SM values obtained at the L4-L5 level (image 21) and 10 cm above L4-L5 (image 23) were strongly related to whole-body SM mass with low SEE values. We used multiple regression analysis to determine whether the combination of thigh and abdominal SM measures explained more of the variance in whole-body SM mass than did the thigh SM measures alone. As shown in Table 4 , midthigh SM area explained 77% and 79% of the variance in whole-body SM mass in men and women, respectively. The addition of L4-L5 SM area to the multiple regression models explained an additional 4% and 3% of the variance in whole-body SM mass in men and women, respectively (P 0.001). Similarly, thigh SM mass explained 84% and 90% of the variance in whole-body SM mass in men and women, respectively. The addition of abdominal SM mass to the multiple regression models explained an additional 8% and 3% of the variance in whole-body SM mass in men and women, respectively (P 0.001). In women, the SEE values were not significantly different (P 0.05) when the combination of abdominal and thigh SM measures (area or mass) was used to predict whole-body SM by comparison with when the thigh measures alone were used to predict whole-body SM (Table 4 ). In men, the SEE values were not significantly different (P 0.05) when the combination of L4-L5 SM area and midthigh SM area was used to predict whole-body SM. However, in men, the SEE values were smaller (P 0.01) when the combination of abdominal and thigh SM mass was used to predict whole-body SM than when thigh SM mass alone was used.
The relation between the 4 regional SM measures and wholebody SM mass is illustrated in Figure 3 . There was a nonlinear relation between thigh SM area and whole-body SM mass in men and women (panel A). For SM area at the L4-L5 image, there was a linear relation with whole-body SM mass in men but a nonlinear relation in women (panel B). Independent of sex, there was a linear relation between the mass of SM in the thigh (panel C) and abdomen (panel D) and whole-body SM mass. Without exception, the slopes and intercepts of the regression lines shown in Figure 3 were not significantly different (P 0.05) in men and women.
DISCUSSION
The findings of the present study show that regional measurements of SM in the thigh are stronger correlates of whole-body SM (R 2 values ͧ0.07-0.21) with lower SEs (relative SEE values 1.1-3.6% lower) than are corresponding measures of SM in the abdomen. However, measures of SM in the abdomen, whether determined from a single image at the L4-L5 level or from a 1 All correlations were significant, P 0.001. SEE is reported as kg (% of whole-body SM).
2 Significantly stronger correlation than for abdominal SM, P 0.05. 3 Significantly stronger correlation than for SM area within the same region, P 0.05. Figure 1 for image locations on the body. 3 x Ȁ SD (all such values). 0.001 1 X 1 (thigh) and X 2 (abdomen) are the first and second independent variables, respectively, that entered the multiple regression model. The value for X 1 is the R 2 for the first variable to enter the multiple regression model, whereas the value for X 2 is the cumulative R 2 for both X 1 and X 2 . SEE is reported as kg (% of whole-body SM). The P value for X 1 represents the significance value when X 1 alone was included in the prediction model. The P value for X 2 represents the P value for the X 2 component of the prediction model that included X 1 and X 2 and not the overall probability value of the prediction model. 2 Significantly different from X 1 , P 0.01. series of images across the abdomen, were also strong correlates of whole-body SM (R 2 values of 0.58 -0.77) with reasonable SEs (SEE values of 6.5-10.4%). This is a novel finding and suggests that a single image at the L4-L5 level, which is more routinely used to obtain surrogate measures of total and abdominal fat, may also act as a surrogate measure of whole-body SM.
It is not surprising that the measures of thigh SM were stronger correlates of whole-body SM mass with lower SEs than were the abdominal measures. At least part of the explanation is mathematical: for example, the thigh SM mass measurement derived by using 7 consecutive images represented 31% and 33% of whole-body SM mass in men and women, respectively. By contrast, the corresponding abdominal SM mass measurement represented 15% of whole-body SM mass in both sexes. Interestingly, the addition of abdominal SM to the thigh SM measurements had a minimal effect on the SEEs for predicting whole-body SM that were observed for the thigh SM measures alone ( Table 4 ). This suggests that if the measurement of SM alone is the primary study outcome, measurement of thigh SM would suffice and, accordingly, the added measurement of abdominal SM would be superfluous. On the other hand, if axial images (MRI or CT) of the abdomen were acquired for the purpose of estimating abdominal adiposity, our findings suggest that the measurement of abdominal SM at L4-L5 would explain another 3-8% of the variance in whole-body SM and would reduce the corresponding SEE by Ȃ1%.
As expected, our findings showed that for men and women, the relation between the SM mass values derived by multiple images (eg, 31-cm region) in the thigh and abdomen were stronger correlates of whole-body SM with lower SEs than were the respective SM area values derived from a single (eg, 1 cm) image (Table  2 ). However, further analysis also showed that not all SM values for the images within the thigh and abdominal regions related to whole-body SM in the same way. Indeed, for the thigh region, independent of sex, the relation between thigh and whole-body SM was best for the 4 images that spanned a 16-cm region beginning 10 cm below the femoral head (Table 3 ). Assuming the purpose of measuring SM in the thigh is to reflect whole-body SM, the implication is that the acquisition of a single MRI or CT image anywhere within this 16-cm region should provide equally strong estimates of whole-body muscle. A similar rationale holds true independent of sex for the region in the abdomen marked by the L4-L5 intervertebral space and 10 cm above (Table 3 ). These observations have practical implications when using CT, because the acquisition of a single image limits the subject's exposure to ionizing radiation. For MRI, exposure to radiation is not a problem, nor is the issue of acquisition time, because the time required to obtain 7 images (eg, in this study, 2 min 46 s in the thigh or 26 s in the abdomen) is not different from the time required to obtain a single image (as the result of characteristics inherent to the acquisition of multiple MRI images in a single acquisition sequence). Furthermore, because changes in SM area differ throughout the thigh region in response to various exercise regimens (eg, resistance or aerobic training) (17), it seems reasonable to suggest that a multiple-image protocol be used when using MRI to determine the effects of a given perturbation on SM mass or distribution.
Whereas MRI and CT images in the abdominal regional have been used extensively in obesity research to examine fat distribution (5, 9) , little is known about whether the SM measures from these images can be used to estimate SM mass (Figure 2 ). Accordingly, an important finding of the present study is that SM area for the commonly used L4-L5 image is a strong indicator of whole-body SM, with R 2 values of Ȃ0.60 and SEE values of Ȃ10%. These results indicate that a single image at the L4-L5 level can be used to obtain estimates of whole-body SM, in addition to abdominal subcutaneous and visceral fat.
Because our study sample was relatively homogeneous (eg, all white and predominantly obese), we made no attempt to develop and cross-validate whole-body SM prediction models that could be applied to the general population. Future studies are needed to extend our findings and develop these algorithms. We did observe that there were curvilinear relations between some of the regional measures of SM and whole-body SM mass, particularly in women (Figure 3 ). The implication of this finding is that a change in abdominal or thigh SM at the lower end of the scale may not reflect the same change in whole-body SM as does a comparable change in abdominal or thigh SM at the upper end of the scale. For example, if 2 women with SM areas of 170 and 250 cm 2 in the midthigh were to each lose 20 cm 2 of SM in that image over a given period of time, our results suggest that the first women would have lost 1.0 kg of SM (17.2-16.2 kg), whereas the second women would have lost 1.5 kg of SM (22.4 -20.9 kg).
In the aforementioned example, there was a loss of SM, which occurs as a natural process of aging, a condition referred to as sarcopenia. We showed previously that sarcopenia progresses at a faster rate in lower-body SM than in upper-body SM (6) , which may cause problems when using regional measures of SM to predict whole-body SM mass or changes in SM mass in an aging population. Similar problems may also arise when using regional measures of SM as indicators of whole-body SM in intervention studies, such as strength training, where an increase in SM would be expected. Training programs that focus on muscle groups in one region of the body (eg, thigh) also measure SM in these regions (17, 18) , and changes in SM in this region would likely not be an accurate reflection of changes in whole-body SM mass. This notion is confirmed in a preliminary report by Abe et al (19) , who observed non-uniform changes in SM hypertrophy across the body in 3 men who performed a 4-mo resistance training program consisting of 3 lower-body and 2 upper-body exercises.
In summary, the findings of the present study suggest that for both men and women, SM values obtained in the thigh are better markers of whole-body SM than are SM values obtained in the abdomen. However, SM values for a single image in a region expanding from L4-L5 to 10 cm above L4-L5 also provide useful estimates of whole-body SM. Because our findings were derived from white men and women, it is unknown whether these findings remain true for other ethnic groups. Future studies should develop and cross-validate prediction models for estimating whole-body SM by the use of single or multiple images in the thigh and abdominal regions. SJL and IJ performed the data analysis; SJL, IJ, and RR wrote the manuscript; and SBH aided in the interpretation and presentation of the results. None of the authors had a conflict of interest.
Letters to the Editor
Effect of changes in fruit and vegetable intake on plasma antioxidant defenses in humans
Dear Sir:
In a recent issue of the Journal, Dragsted et al (1) investigated whether fruit and vegetable intake affects biomarkers of oxidative stress or antioxidant defenses. They conducted a well-designed, 25-d, randomized, partly blinded intervention trial. Some of their conclusions related to an apparent lack of effect on markers of total antioxidant capacity [TAC; namely, the ferric-reducing ability of plasma (FRAP) and Trolox-equivalent antioxidant capacity (TEAC)], most of the enzymatic antioxidant defenses (superoxide dismutase, catalase, glutathione reductase, and glutathione S-transferase), and lipid oxidation (isoprostanes and malondialdehyde) in the fruit and vegetable (fruveg) group compared with the placebo group.
TAC measurement, representing the cumulative action of all electron-donating antioxidants present in body fluids, is increasingly being used to monitor redox status in vivo in intervention, bioavailability, and epidemiologic studies (2, 3) . However, different studies have indicated that there may be a physiologic modulation of the redox status of body fluids (4, 5) , and results from the SU.VI.MAX intervention trial indicate the importance of baseline plasma concentrations on the effectiveness of antioxidant supplementation (6) . Therefore, dietary effects on the redox status of healthy subjects may be small and difficult to discern, especially if nonoptimized assay conditions are used. We suggest that the lack of significant variation in plasma antioxidant defenses observed by Dragsted et al may be a consequence of these factors. First, the dietary change failed to modify the redox status of the healthy subjects during the experimental period (see Table 6 in reference 1) and, second, the plasma TAC data could have been adversely affected by suboptimal measurement conditions. The data of Dragsted et al clearly show that none of the measured redox markers were affected by the withdrawal of fruit and vegetables from the control diet. A decrease in plasma antioxidant concentrations was observed only with vitamin C and carotenoids, which in humans are modest contributors to plasma TAC (7, 8) . We speculate that this indicates that 25 d was not an adequate time period to impair plasma TAC in healthy subjects. Because of the ability to cope with light dietary stress, plasma antioxidant defenses may need 25 d or specific and stronger dietary stresses, such as a high-fat diet, to be challenged significantly. We believe that the lack of change in plasma TAC concentrations in the placebo and fruveg groups could have been due to a physiologic regulatory mechanism that in the short term buffers against significant variation in plasma TAC in healthy young subjects (26 Ȁ 6 y for the fruveg group and 29 Ȁ 8 y for the placebo group).
The lack of observed changes in plasma FRAP and TEAC could also be the result of a decrease in the sensitivity of the TAC measurements as the result of nonoptimized assay techniques. The wavelength used by Dragsted et al to measure both FRAP and TEAC was 620 nm. The correct reference wavelengths are 595 nm for the FRAP assay and 734 nm for the TEAC assay (9, 10). Experiments conducted in our laboratories indicate that measurement at 620 nm results in a decrease in sensitivity of Ȃ40% and 66% for TEAC and FRAP, respectively. This is borne out by the uncharacteristically high CVs (16.6% and 8.8%, respectively, for TEAC and FRAP) obtained by Dragsted et al compared with reference studies (9, 10) . The difference in vitamin C concentration between the fruveg and the placebo group at the end of the supplementation period was Ȃ60 mol/L (Figure 2 in reference 1) . The expected relative difference in TAC, based on the stoichiometry of ascorbic acid, should have been Ȃ10% for FRAP (10) . This small, but generally discernable, effect on TAC, may have been masked by the reduced sensitivity of the TAC protocols applied in this study.
In conclusion, this interesting and valuable study by Dragsted et al (1) highlights both a requirement for optimized assay conditions and the need to consider the possibility of dynamic mechanisms of control of the body's redox defenses when designing human intervention studies with dietary antioxidants. Measurements of TAC (the sum of the parts) and of single antioxidants (parts of the sum) are useful biomonitoring tools in supplementation and health-related studies of redox balance. However, an understanding of the physiologic mechanisms of control of the body's redox defenses is an important issue that must be addressed to clarify the role of dietary antioxidants in disease prevention.
None of the authors had any conflict of interest.
Mauro Serafini
Antioxidant Research Laboratory at the Unit of Human Nutrition Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN) Rome Italy
Iris F F Benzie
Ageing and Health Section Faculty of Health and Social Sciences The Hong Kong Polytechnic University Kowloon Hong Kong China
Reply to M Serafini et al
We appreciate the comments on our paper (1) made by Serafini et al, who highlight some important problems in the interpretation and power of biomarker-based human intervention studies. Serafini et al's letter contains 2 major points of criticism. The first concerns the possibility that our intervention period of 25 d was insufficient to observe a change in fasting measures of antioxidant capacity without an added dietary oxidant stress, such as increased fat. Relatively few human intervention studies have actually been able to show differences in antioxidant capacity, and as far as we are aware, all of these found only postprandial effects. This is the case for studies of tea and chocolate, which have been shown to result in short-term increases in markers of antioxidant capacity equivalent to the increased plasma concentration of catechins (2) (3) (4) (5) (6) . The tomato study mentioned by Serafini et al also came to this conclusion (7) . In another study, the intervention of 20 -25% changes in fat or total energy intake for 12 wk was insufficient to elicit observable changes in plasma antioxidant capacity (8) .
Thus, we can speculate that prolonged dietary changes are necessary to affect antioxidant capacity. For example, the lifestyle factors leading to type 2 diabetes also result in chronic decreases in plasma antioxidant capacity, apparently as the result of changes in uric acid metabolism (9, 10) . Whether fruit and vegetables would counteract this effect in the long run remains to be investigated. Therefore, our conclusion that a large intake of fruit and vegetables does not affect fasting plasma measures of antioxidant capacity seems valid and in accordance with the literature.
The second criticism concerns our method for measuring plasma antioxidant capacity. According to Serafini et al, an increase in the measurement error may have resulted in our failure to detect minor changes, such as the 10% change calculated from the drop in ascorbate concentrations. Our automated assay of the ferric-reducing ability of plasma (FRAP) and Trolox-equivalent antioxidant capacity (TEAC) was optimized within the boundaries of our equipment, eg, with the absorbance filters available. This decreased sensitivity offset the absolute values of TEAC and increased intra-assay variability compared with the same assays on other equipment. We agree that the intra-day CV of our standard plasma sample was high and understand the concerns of Serafini et al. We have reinvestigated the cause of this and found that other samples and our calibrators had much lower variability, indicating some unidentified problem with our standard plasma. In these other samples, our intra-assay variation was still higher (6.7% for TEAC and 3.9% for FRAP) than the reference values cited in the literature (11, 12) . However, this is unlikely to have caused a type I error in our study because the interindividual variability in FRAP and TEAC was still much higher than the assay variability. The measurement error therefore has relatively little influence on the actual power to detect differences. We observed an overall interindividual CV at baseline of 11.2% for TEAC (x Ȁ SD: 885 Ȁ 99 mol/L) and 22.5% for FRAP (x Ȁ SD: 693 Ȁ 156 mol/L) in the fasting samples (n ҃ 43). In the postprandial samples, the variation was 17.0% and 26.7% (n ҃ 28), respectively. In papers by others, including those cited by Serafini et al, the interindividual CVs for plasma antioxidant activities are variable but similar to ours, eg, 20.6% for FRAP [n ҃ 141 (11)], 21.7% for total radical-trapping antioxidant potential [n ҃ 11 (7) ], 9.6% for TEAC [n ҃ 312 (12)], and 18.3% for oxygen radical absorbance capacity [n ҃ 60 (13) ].
In our study (1), we tried to increase power by looking at the time course during the intervention with a repeated-samples analysis of covariance (ANCOVA) that used each volunteer's value at baseline as a covariate. In this analysis, the analytic error becomes more important for the power because the interindividual differences are balanced out. However, it still depends on the intraindividual (interday) variation, which in our study was 9.3% for FRAP and 11% for TEAC. This leads to a power of 70% to detect a significant 10% change in TEAC or FRAP [determined by G-power (14) as a post hoc analysis]. In addition to the values at baseline and at the end of intervention (25 d), we measured plasma antioxidant capacity 3, 9, and 16 d after the start of the intervention and 8 and 29 d after the volunteers had resumed their habitual diet. As seen in Figure 1 , there is no indication of deviations from the initial or post-intervention values, as we also confirmed by repeated-samples ANCOVA. In the case of FRAP, the known difference of 25% between men and women (11) was readily observable at all time points, which indicates to us that we would have seen some indication of a 10% change in fasting blood samples. Moreover, the groups with higher initial values were stable throughout.
In conclusion to this point, we agree that our assay sensitivity was probably not optimal and that our absolute values for TEAC may have been offset by the shortcomings of our automated equipment. However, we disagree that this seriously affected our power to detect a real change in measures of antioxidant capacity. The major source of noise in the measurement of plasma antioxidant capacity is the interindividual variation, which was similar in our study to that observed by others, including the cited reference studies. Consequently, we still conclude that there was no significant effect of fruit and vegetables on fasting plasma antioxidant capacity within the 25-d study period.
None of the authors had any conflict of interest related to the results and discussion published in this letter. and fasting plasma Trolox-equivalent antioxidant capacity (TEAC) determined according to reference 1 in samples collected before (day 0), during (days 3-25), and after (days 33 and 54) intervention with 600 g fruits and vegetables (᭜); a corresponding supplement containing nutrients, vitamins, and minerals (OE); or a placebo pill plus an energy-balancing drink (■). The start and end of the intervention are marked with vertical arrows. None of the groups differed significantly at any time point by repeated-samples analysis of covariance.
LO Dragsted
Body mass index and survival in incident dialysis patients: the answer depends on the question
In a recent issue of the journal, Johansen et al (1) examined an important question-What is the association of body size with survival adjusted for muscle mass in incident dialysis patients? However, there are really 3 questions: 1) What is the independent association between muscle mass and mortality, 2) What is the independent association between BMI and mortality, and 3) How does mortality vary across different levels of BMI and muscle mass combined. Based on the answer to the question posed by Johansen et al, inferences on whether body composition influences the survival of incident dialysis patients with a high BMI could not be drawn.
We reexamined the data from our earlier study (2) , which the authors graciously discussed. Details on study population, inclusion criteria, data collection, and statistical methods were described earlier (2) . In 70 028 incident hemodialysis patients in the United States, from 1 January 1995 to 31 December 1999, the associations of BMI categories described by Johansen et al with survival were examined in a multivariable parameteric proportional hazards survival model adjusted for urinary creatinine, demographics, comorbid conditions, serum albumin, and functional status. The results (Figure 1) are similar to those reported by Johansen et al.
To further examine the influence of body composition on survival in high-BMI patients, each of the BMI groups was divided into groups on the basis of muscle mass: low (urinary creatinine ͨ25th percentile, ie, ͨ0.55 g/d), normal, or high (urinary creatinine 0.55 g/d) subgroups. The hazard ratios from the multivariable parameteric proportional hazards survival model, adjusted for all of the above factors except urinary creatinine, are presented in Figure 2 .
At first glance, Figures 1 and 2 appear contradictory, but, in reality, they are not. Adjustment for urinary creatinine in the multivariable model (Figure 1 ) does not mean that the hazard of death is constant across the spectrum of urinary creatinine values in any given BMI group (Figure 2 ). Whether the association of BMI with survival is confounded by muscle mass is examined in Figure 1 . Whether those with a large body size but low muscle mass have a survival advantage over "healthy" patients with a normal BMI and a normal or high muscle mass is examined in Figure 2 .
In our study we summarized the findings in Figure 2 as "the survival advantage conferred by high BMI in dialysis patients is limited to patients with normal or high muscle mass." We understand the concerns of Johansen et al that this could be construed as independence. We rephrase our conclusions as follows. Patients with a 
